Allometric or lean body mass scaling of propofol pharmacokinetics: Towards simplifying parameter sets for target-controlled infusions

Clinical Pharmacokinetics

Volumn 51, Issue 3, 2012, Pages 137-145

  Coetzee, Johan Francois ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Infusion pumps; Pharmacokinetics; Pharmacology; Propofol

Indexed keywords

PROPOFOL;

ADOLESCENT; ADULT; AGED; ALLOMETRY; ARTICLE; CHILD; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; INFUSION PUMP; LEAN BODY WEIGHT; MALE; MORBID OBESITY; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROCESS MODEL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANESTHETICS, INTRAVENOUS; BODY SIZE; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; DRUG DOSAGE CALCULATIONS; HUMANS; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; LINEAR MODELS; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY, MORBID; PROPOFOL; YOUNG ADULT;

EID: 84857070830     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/11596980-000000000-00000     Document Type: Article

References (66)

1. von Neumann J. The mathematician. In: Heywood RB, editor. The works of the mind. Chicago (IL): University of Chicago Press, 1947
2. Minto CF, Schnider TW. Contributions of PK/PD modeling to intravenous anesthesia. Clin Pharmacol Ther 2008; 84 (1): 27-38 (Pubitemid 351861500)
3. Marsh B, White M, Morton N, et al. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67 (1): 41-8
4. Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88 (5): 1170-82 (Pubitemid 28216859)
5. Coetzee JF, Glen JB, Wium CA, et al. Pharmacokinetic model selection for target controlled infusions of propofol: assessment of three parameter sets. Anesthesiology 1995; 82 (6): 1328-45
6. Glen JB, Servin F. Evaluation of the predictive performance of four pharmacokinetic models for propofol. Br J Anaesth 2009; 102 (5): 626-32
7. Absalom AR, Mani V, De Smet T, et al. Pharmacokinetic models for propofol: defining and illuminating the devil in the detail [published erratum appears in Br J Anaesth 2010 Mar; 104 (3): 393]. Br J Anaesth 2009; 103 (1): 26-37
8. Engbers FH, Sutcliffe N, Kenny G, et al. Pharmacokinetic models for propofol: defining and illuminating the devil in the detail. Br J Anaesth 2010; 104 (2): 261-2
9. Enlund M. TCI: target controlled infusion, or totally confused infusion? Call for an optimised population based pharmacokinetic model for propofol. Ups J Med Sci 2008; 113 (2): 161-70
10. Gepts E, Camu F, Cockshott ID, et al. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66 (12): 1256-63 (Pubitemid 18024603)
11. Albertin A, Poli D, La Colla L, et al. Predictive performance of 'Servin's formula' during BIS-guided propofol-remifentanil target-controlled infusion in morbidly obese patients. Br J Anaesth 2007; 98 (1): 66-75 (Pubitemid 44896753)
12. La Colla L, Albertin A, La Colla G, et al. No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients. Eur J Anaesthesiol 2009; 26 (5): 362-9
13. Coetzee JF. Total intravenous anaesthesia to obese patients: largely guesswork? Eur J Anaesthesiol 2009; 26 (5): 359-61
14. Shangguan WN, Lian Q, Aarons L, et al. Pharmacokinetics of a single bolus of propofol in Chinese children of different ages. Anesthesiology 2006; 104 (1): 27-32
15. Kataria BK, Ved SA, Nicodemus HF, et al. The pharmacokinetics of propofol in children using three different data analysis approaches. Anesthesiology 1994; 80 (1): 104-22 (Pubitemid 24033610)
16. Absalom A, Kenny G. 'Paedfusor' pharmacokinetic data set. Br J Anaesth 2005; 95 (1): 110
17. Absalom A, Amutike D, Lal A, et al. Accuracy of the 'Paedfusor' in children undergoing cardiac surgery or catheterization. Br JAnaesth 2003; 91 (4): 507-13 (Pubitemid 37258593)
18. Engelhardt T, McCheyne AJ, Morton N, et al. Clinical adaptation of a pharmacokinetic model of propofol plasma concentrations in children. Paediatr Anaesth 2008; 18 (3): 235-9 (Pubitemid 351159907)
19. Rigouzzo A, Servin F, Constant I. Pharmacokinetic-pharmacodynamic modeling of propofol in children. Anesthesiology 2010; 113 (2): 343-52
20. Ingrande J, Brodsky JB, Lemmens HJ. Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects. Anesth Analg 2011; 113 (1): 57-62
21. Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303-32 (Pubitemid 351738156)
22. Cortinez LI, Anderson BJ, Penna A, et al. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth 2010; 105 (4): 448-56
23. Knibbe CA, Zuideveld KP, Aarts LP, et al. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults. Br J Clin Pharmacol 2005; 59 (6): 705-11 (Pubitemid 40835504)
24. Peeters MY, Allegaert K, Blusse van Oud-Alblas HJ, et al. Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model. Clin Pharmacokinet 2010; 49 (4): 269-75
25. Schuttler J, Ihmsen H. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 2000; 92 (3): 727-38 (Pubitemid 30130176)
26. van Kralingen S, Diepstraten J, Peeters MYM, et al. Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients. Clin Pharmacokinet 2011; 50 (11): 739-50
27. Allegaert K, de Hoon J, Verbesselt R, et al. Maturational pharmacokinetics of single intravenous bolus of propofol. Paediatr Anaesth 2007; 17 (11): 1028-34 (Pubitemid 47481127)
28. Peeters MY, Prins SA, Knibbe CA, et al. Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery. Anesthesiology 2006; 104 (3): 466-74
29. Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol 2004; 58 (2): 119-33 (Pubitemid 39043992)
30. Wulfsohn NL, Joshi CW. Thiopentone dosage based on lean body mass. Br J Anaesth 1969; 41 (6): 516-21
31. Leslie K, Crankshaw DP. Lean tissue mass is a useful predictor of induction dose requirements for propofol. Anaesth Intensive Care 1991; 19 (1): 57-60
32. JamesWPT. Research on obesity: a report of the DHSS/MRCGroup. London, Her Majesty's Stationery Office, 1976
33. Janmahasatian S, Duffull SB, Ash S, et al. Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44 (10): 1051-65 (Pubitemid 41356391)
34. McLeay SC, Morrish GA, Kirkpatrick CM, et al. Encouraging the move towards predictive population models for the obese using propofol as a motivating example. Pharm Res 2009; 26 (7): 1626-34
35. Crankshaw DP, Boyd MD, Bjorksten AR. Plasma drug efflux: a new approach to optimization of drug infusion for constant blood concentration of thiopental and methohexital. Anesthesiology 1987; 67 (1): 32-41 (Pubitemid 18003424)
36. Crankshaw DP, Brown MJ, Bjorksten AR. A comparison of parametric and non-parametric approaches to target-controlled infusion of propofol. Anaesth Intensive Care 2010; 38 (3): 437-44
37. Servin F, Farinotti R, Haberer JP, et al. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide: a clinical and pharmacokinetic study. Anesthesiology 1993; 78 (4): 657-65 (Pubitemid 23110039)
38. Schwilden H, Schuttler J, Stoekel H. Pharmacokinetics as applied to total intravenous anaesthesia: theoretical considerations. Anaesthesia 1983; 38 Suppl.: 51-2 (Pubitemid 13062465)
39. Minto C, Schnider T. PKPD tools for Excel software [online]. Available from URL: http://www.pkpdtools.com/doku.php/start [Accessed 2011 Dec 18]
40. Collis T, Devereux RB, Roman MJ, et al. Relations of stroke volume and cardiac output to body composition: the Strong Heart Study. Circulation 2001; 103 (6): 820-5 (Pubitemid 32163879)
41. Ludbrook GL, Upton RN. A physiological model of induction of anaesthesia with propofol in sheep: 2. Model analysis and implications for dose requirements. Br J Anaesth 1997; 79 (4): 505-13 (Pubitemid 27423331)
42. Upton RN, Ludbrook GL, Grant C, et al. Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration. Anesth Analg 1999; 89 (3): 545-52 (Pubitemid 29409795)
43. World Society of Intravenous Anaesthesia. The WorldSIVA Open TCI Initiative [online]. Available from URL: http://opentci.org/doku.php?id=start [Accessed 2011 Dec 18]
44. Masui K, Upton RN, Doufas AG, et al. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data. Anesth Analg 2010; 111 (2): 368-79
45. Miller D.Miller's anesthesia. 7th (electronic) ed. Philadelphia (PA): Elsevier, 2011
46. Calvey TN, Williams N. Principles and practice of pharmacology for anaesthetists. 5th ed. Malden (MA): Blackwell Publishing, Inc., 2008
47. Dundee JW, Clarke RSJ, McCaughey W. Clinical anaesthetic pharmacology. Edinburgh: Churchill Livingstone, 1991
48. Evers AS, Maze M. Anesthetic pharmacology. New York: Churchill Livingstone, 2004
49. Fee JPH, Bovill JG. Pharmacology for anaesthesiologists. London: Taylor & Francis, 2005
50. Hemmings HC Jr, Hopkins PM. Foundations of anesthesia. 2nd ed. Philadelphia (PA): Elsevier Mosby, 2006
51. Hull CJ. Pharmacokinetics for anaesthesia. Oxford: Butterworth Heinemann, 1991
52. Peck TE, Hill S, Williams MA. Pharmacology for anaesthesia and intensive care. Cambridge: Cambridge University Press, 2008
53. Stanley TH, Egan T. Anesthesia for the new millennium: modern anesthetic clinical pharmacology. Dordrecht: Kluwer Academic Publishers, 1999
54. Vickers MD, Morgan M, Spencer PSJ, et al. Drugs in anaesthetic and intensive care practice. 8th ed. London: Butterworth Heinemann, 1999
55. Wood M, Wood A. Drugs and anesthesia: pharmacology for anesthesiologists. 2nd ed. Baltimore (MD): Williams & Wilkins, 1990
56. Goldman CA, Snell RR, Thomason JJ. Principles of allometry. In: Goldman CA, editor. Tested studies for laboratory teaching: proceedings of the Eleventh Workshop/Conference of the Association for Biology Laboratory Education. Toronto: Association for Biology Laboratory Education 1990: 43-72 [online]. Available from URL: http://www.ableweb.org/volumes/vol-11/4-goldman.pdf [Accessed 2011 Dec 20]
57. Mahmood I. Interspecies scaling: predicting volumes, mean residence time and elimination half-life: some suggestions. J Pharm Pharmacol 1998; 50 (5): 493-9 (Pubitemid 28241135)
58. Kleiber M. Body size and metabolism. Hilgardia 1932; 6: 315-53
59. Kleiber M. Body size and metabolic rate. Physiol Rev 1947; 27 (4): 511-41
60. Brody S. Bioenergetics and growth. New York: Reinhold Publishing Corporation, 1945
61. West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997; 276 (5309): 122-6 (Pubitemid 27161259)
62. West GB, Brown JH, Enquist BJ. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999; 284 (5420): 1677-9 (Pubitemid 29291379)
63. Banavar JR, Maritan A, Rinaldo A. Size and form in efficient transportation networks. Nature 1999 May 13; 399 (6732): 130-2
64. McMahon T. Size and shape in biology. Science 1973; 179 (79): 1201-4
65. Mahmood I. Theoretical versus empirical allometry: facts behind theories and application to pharmacokinetics. J Pharm Sci 2010; 99 (7): 2927-33
66. White CR, Seymour RS. Allometric scaling of mammalian metabolism. J Exp Biol 2005; 208 (Pt 9): 1611-9 (Pubitemid 40697609)